Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases

Masanam, HB; Perumal, G; Krishnan, S; Singh, SK; Jha, NK; Chellappan, DK; Dua, K; Gupta, PK; Narasimhan, AK

Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases

Masanam, HB Perumal, G Krishnan, S Singh, SK Jha, NK Chellappan, DK Dua, K

Gupta, PK Narasimhan, AK

Permalink

Publisher:: Future Medicine Ltd
Publication Type:: Journal Article
Citation:: Nanomedicine

Closed Access

	Filename	Description	Size
	Nanoimaging_Ashvin_nnm-2021-0427 (1).pdf	Published version	1.68 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Masanam, HB
dc.contributor.author	Perumal, G
dc.contributor.author	Krishnan, S
dc.contributor.author	Singh, SK
dc.contributor.author	Jha, NK
dc.contributor.author	Chellappan, DK
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.contributor.author	Gupta, PK
dc.contributor.author	Narasimhan, AK
dc.date.accessioned	2023-01-26T14:30:36Z
dc.date.available	2023-01-26T14:30:36Z
dc.identifier.citation	Nanomedicine
dc.identifier.issn	1743-5889
dc.identifier.issn	1748-6963
dc.identifier.uri	http://hdl.handle.net/10453/165498
dc.description.abstract	<jats:p> The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable better spatial–temporal resolution and a high signal-to-noise ratio in imaging. Targeted nanoimaging agents have been used to bind specific tissues in inflammatory lungs for early-stage diagnosis. However, nanobased imaging approaches for inflammatory lung diseases are still in their infancy. This review provides a solution-focused approach to exploring medical imaging technologies and nanoprobes for the detection of inflammatory lung diseases. Prospects for the development of contrast agents for lung disease detection are also discussed. </jats:p>
dc.language	en
dc.publisher	Future Medicine Ltd
dc.relation.ispartof	Nanomedicine
dc.relation.isbasedon	10.2217/nnm-2021-0427
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	0306 Physical Chemistry (incl. Structural), 1004 Medical Biotechnology, 1007 Nanotechnology
dc.subject.classification	Nanoscience & Nanotechnology
dc.title	Advances and opportunities in nanoimaging agents for the diagnosis of inflammatory lung diseases
dc.type	Journal Article
utslib.for	0306 Physical Chemistry (incl. Structural)
utslib.for	1004 Medical Biotechnology
utslib.for	1007 Nanotechnology
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy
utslib.copyright.status	closed_access	*
dc.date.updated	2023-01-26T14:30:27Z
pubs.publication-status	Published online

Abstract:

The development of rapid, noninvasive diagnostics to detect lung diseases is a great need after the COVID-2019 outbreak. The nanotechnology-based approach has improved imaging and facilitates the early diagnosis of inflammatory lung diseases. The multifunctional properties of nanoprobes enable better spatial–temporal resolution and a high signal-to-noise ratio in imaging. Targeted nanoimaging agents have been used to bind specific tissues in inflammatory lungs for early-stage diagnosis. However, nanobased imaging approaches for inflammatory lung diseases are still in their infancy. This review provides a solution-focused approach to exploring medical imaging technologies and nanoprobes for the detection of inflammatory lung diseases. Prospects for the development of contrast agents for lung disease detection are also discussed.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/165498